Department of Neurology, National Taipei University of Technology, Taipei, Taiwan.
Taiwan J Obstet Gynecol. 2010 Dec;49(4):395-400. doi: 10.1016/S1028-4559(10)60088-5.
Stroke is a rare but potentially devastating disease during pregnancy and puerperium. Pregnancy is well recognized as a risk factor for stroke. Accurate and timely identification of stroke is crucial for clinical practice. However, the optimal management of pregnant women with stroke remains a clinical challenge. Thus, identification of risk factors and modification of underlying pathophysiological mechanisms would be of great value for stroke prevention and management. In terms of pharmacological intervention, it is important to determine the safety of a drug for mothers, their fetuses, and nursing infants. Neurologists treat non-pregnant patients without those considerations. Based on the above issues, we have reviewed the current literature and summarized clinically relevant issues for obstetricians and neurologists in treating stroke during pregnancy and puerperium.
脑卒中是妊娠期和产褥期罕见但潜在致命的疾病。妊娠是公认的脑卒中危险因素。准确及时地识别脑卒中对于临床实践至关重要。然而，脑卒中孕妇的最佳管理仍然是临床挑战。因此，确定风险因素并调整潜在的病理生理机制对于脑卒中的预防和管理具有重要价值。在药物干预方面，确定药物对母亲、胎儿和哺乳期婴儿的安全性非常重要。神经科医生在治疗非妊娠患者时不会考虑这些因素。基于上述问题，我们复习了当前的文献，并总结了妇产科医生和神经科医生在治疗妊娠期和产褥期脑卒中时的临床相关问题。
